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Background: Capgras delusion is a delusional misidentification syndrome, in which the patient is convinced
that someone that is well known to them, usually a close relative, has been replaced by an impostor or double.
Although it has been frequently described in psychotic syndromes, including paranoid schizophrenia, over a
third of the documented cases of Capgras delusion are observed in patients with organic brain lesions or
neurodegenerative disease, including Parkinson’s Disease. Variants of Capgras involving animals or inanimate
objects have also been described. The etiology of Capgras in Parkinson’s remains unclear, but may arise from
a combination of factors, such as frontal lobe dysfunction and dopaminergic medication.
Case presentation: We present the case of a 53-year old right-handed female with Parkinson’s disease who
developed Capgras delusion during treatment with dopamine agonists and Levodopa/Carbidopa. She became
convinced that her pet dogs and the plants in her garden had been substituted by identically looking ones.
Our patient was initially treated with Quetiapine, with no improvement, and subsequently treated with Clozapine,
which lead to partial regression of her symptoms. Neuropsychological Evaluation showed Mild Cognitive Impairment in
Executive Functions.
Conclusions: Given the clinical history, onset and evolution of symptoms we believe our patient’s delusion resulted
from the overlap of dopaminergic medication and Mild Cognitive Impairment in executive functions. Zoocentric
Capgras, the variant we describe, has been rarely described in scientific literature, and we believe it is of
interest due to its unusual characteristics.
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Capgras delusion is a delusional misidentification syn-
drome, in which patients become convinced that someone
close to them has been replaced by an impostor. Joseph
Capgras first described this delusion in 1923, and called
it “l’illusion des sosies”. Capgras and Reboul-Lachaux
described the case of a woman who, among other psych-
otic symptoms, developed the delusional belief that her
husband, children, neighbors, and others had been re-
placed by doubles [1,2]. Capgras syndrome involving
animals or inanimate objects has been rarely described in
scientific literature [3-5].
Although it has been frequently described in psychotic
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unless otherwise stated.a third of the documented cases of Capgras syndrome
occur in patients with organic brain lesions, suggesting
that the syndrome may have an organic etiology [8,10,11].
Capgras may also be observed in Parkinson’s Disease (PD)
[12,13], and may arise as a consequence of dopaminergic
medication and frontal lobe dysfunction.
Case presentation
Our patients is a 53-year old right-handed Caucasian
female, who has been married for over 20 years, has a
20 year old son, and works with her husband in a family
run business. She initially presented with tremor and
stiffness, predominantly on her right side, in 2011, for
which her GP referred her to Istituto Neurologico Besta.
Clinical history was unremarkable, and there was no
family history of psychiatric or movement disorders. She
underwent a DAT-scan in September 2012, which re-
vealed presynaptic dopaminergic deficit. At the time, herhis is an Open Access article distributed under the terms of the Creative
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toms were noted at the outpatient visits or were reported
by family members. Brain MRI was normal. She was diag-
nosed with PD, and in March 2013 she was started on ex-
tended release Pramipexole up to 2.1 mgs, with moderate
improvement in her motor symptoms. The medication
choice was dictated by the evidence of lower risk in motor
complications compared to levodopa, in keeping with
current treatment guidelines [14]. In July 2013, Levodopa/
Carbidopa at the dose of 100/25 mg 3 times daily was
added to her medication, and led to significant improve-
ment of motor symptoms. In the summer of 2013 her
husband noticed hyperactivity and a dramatic increase in
her hobby activity: aside from excessive goal directed
activity, he did not report other symptoms such as mood
elevation, dysphoria, reduced need for sleep or grandiosity;
the patient’s hyperactivity regressed after Pramipexole
was withdrawn (whereas Levodopa/Carbidopa was main-
tained). Towards the end of November 2013 she started
experiencing delusional symptoms: one day she noticed
something strange in the behavior of some of the handy-
men she had hired to do some work around the house.
She also became convinced that some of the paintings in
her house had been replaced, and that the frames also
seemed different. In the following days she noticed that
her dogs had also been replaced: the impostors were
almost identical to the original dogs but they had a slightly
different color and their spots were in different places. She
became convinced that the cypresses in her garden had
been replaced as well, and she was quite sure about this
because the new trees were younger and smaller than the
original ones. When asked who was responsible for
replacing them or what may have lead them to do such a
thing she stated that she herself was puzzled about this,
and that she found all these events very bizarre. She was
also unable to pinpoint the exact differences between the
impostors and the original objects and pets. When asked
why she thought her husband or others around her could
not notice these differences she said she was not sure, but
she thought this might be explained by the fact that they
only superficially observed the objects, plants and animals.
Interestingly, her delusion never involved her family mem-
bers or other people close to her. In October, a psychiatric
consultation was requested: mood and affect were normal,
her Structured Clinical Interview for DSM-IV Axis I Disor-
ders (SCID-I) did not reveal any previous symptoms con-
sistent with a diagnosis of lifetime or current affective,
anxiety, substance abuse, eating or somatoform disorder.
Her Brief Psychiatric Rating Scale (BPRS) score at the time
was 38, indicating a ‘moderatly ill’ patient. The patient
symptoms were consistent with a diagnosis of current
delusional disorder, for which she started on a low dose of
Quetiapine (50 mg) with no significant improvement in
psychiatric symptoms: she was very worried and anxious,and she rapidly became irritable when she was contra-
dicted by either her husband or her doctors. The choice
of Quetiapine over other medication was dictated by
a relatively favorable motor side effect profile compared
to other anitpyshcotics; the choice of Quetiapine over
Clozapine as a first line medication was motivated by the
possbile side effects of Clozapine (particularly agranuloci-
tosis) and the fact that Clozapine therapy requires weekly
monitoring of blood panel for 18 weeks.
The patient did not undergo any further brain imaging. In
April 2014 the patient was started on low dose Clozapine,
starting with 12.5 mgs, and slowly increased to 50 mgs, and
her symptoms partially regressed. The dose of Clozapine
could not be increased further due to sedation. At her last
evaluation in November 2014 she was euthymic, had
gained insight about her delusion, and had good social
and work functioning. The delusions had not completely
disappeared, and she still sometimes had the feeling that
some items might have been replaced. However, the de-
gree of conviction about the delusions had significantly
decreased, and her and anxiety has improved dramatically.
BPRS score was 23.
Neuropsychological assessment
The patient underwent neuropsychological evaluation in
September 2014 (Table 1). Her Montreal Cognitive
Assessment (MoCA) was impaired. Memory, praxia, face
recognition, visual object and space perception were nor-
mal. The patient was slighty impaired in graphic fluency
and had a few slips of attention. There was no evidence of
functional impairment. Global assessment fulfilled diag-
nostic criteria for Mild Cognitive Impairment (MCI) in
PD [15] single domain (executive functions).
All the procedures described in the above sections are
in compliance with the Declaration of Helsinski and were
approved by the Ethics Committee at Istituto Neurologico
Carlo Besta.
Conclusions
Capgras is a relatively rare delusion, and is mostly de-
scribed in patients with concomitant brain lesions or neu-
rodegenerative disease, including PD [11,12,17]. Typical
Capgras delusion involves a close relative, thought there
have been some reports of Capgras involving animals [5]
and inanimate objects [3,4].
Face perception is a function with significant complex-
ity, which is reflected in hierarchical cognitive models.
Current neuroimaging data show that face perception
involves a core-processing network of cortical modules,
each of which is specialized in different functions in-
volved in face processing [18-20]. Overall it is a highly
specialized network, and differs from other visual infor-
mation processing [21-23]. Capgras delusion can be con-
sidered a disorder of face processing, and some studies
Table 1 Neuropsychological assessment
Raw score* Adjusted score or cut-off Equivalent score or classification
Montreal Cognitive Assessment 21/30 17.16 0
Memory
Verbal memory
Digit span (forward) 6 5.75 3
Rey 15 word test
Learning 38/75 35.7 2
Recall 6/15 5.40 1
Recognition 12/15 Average
Visual memory
Visuo-spatial span (forward) 5 4.74 2
Rey-Osterrieth Complex figure Test (RCFT) Recall 12.5/36 13.55 3
Attention and executive functions
Digit span (backward) 4 3.71 2
Visuo-spatial span (backward) 5 4.67 4
Multiple Features Target Cancellation (MFTC)
Time 37 ≤135.73 Average
Correct items 12 ≥8.53 Average
False alarm 0 ≤2.77 Average
Accuracy 0.96 ≥0.869 Average
Stroop color naming
Time interference 18 17.75 4
Error interference 1 1.05 3
Trail Making Test
Part A 39 33.60 4
Part B 80 66 4
B-A 41 32.40 4
Phonemic fluency 25 21.90 1
Cognitive Estimation Test (CET)
Errors 18 ≤19 Average
“Bizarre” errors 5 ≤5 Borderline
Modified Five Point Test
Drawings 16 ≥23.84 Impaired
Number of strategies 2 3.39 2
Language and perception
Semantic fluency 49 46.90 4
Famous face naming test 78/78 ≥53 Average
Benton facial recognition test 47/54 47 Average
Clock drawing 9/10 ≥7 Average
Rey-Osterrieth Complex figure Test (RCFT) Copy 34/36 33.65 4
Visual Object and Space Perception Battery (V.O.S.P.)
Object perception
Screening 20/20 ≥15 Average
Incomplete letters 19/20 ≥16 Average
Silhouettes 26/30 ≥15 Average
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Table 1 Neuropsychological assessment (Continued)
Object identification 19/20 ≥14 Average
Progressive silhouettes 8/20 ≤15 Average
Spatial perception
Counting 10/10 ≥8 Average
Position discrimination 20/20 ≥18 Average
Number localization 7/10 ≥7 Borderline
Cube analysis 10/10 ≥6 Average
*Legend: Raw score: score test; Adjusted score: obtained by adding or subtracting the contribution of patient’s age and education; Equivalent score: adjusted scores
converted to a five-point interval scale, from 0 to 4 equivalent scores. The five- point interval scale is divided as follows: 0 = scores equal or lower than the outer
tolerance limit (5%); 4 = scores higher than the median value of the whole sample; 1, 2 and 3 are obtained by dividing into three equal parts the area of distribution
between 0 and 4 [16].
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prosopoagnosia [24], which is characterized by impaired
face recognition, usually arising as a result of bilateral
lesions in the inferior temporal lobes [18,25,26]. Con-
trary to prosopoagnosia, however, patients suffering from
Capgras delusion are not impaired in overt face recogni-
tion, which is mediated by the ventral route from the visual
centers to the temporal lobes, but the dorsal visual route,
which is crucial for attribution of emotional significance to
a face, is damaged [24]. Physiological studies in patients
with Capgras delusion have shown impaired autonomic
arousal to familiar faces, which may underpin the belief
that others have been replaced by impostors [27-29].
These neurobiological mechanisms, however, only ex-
plain the absence of emotional significance which occurs
while viewing a familiar face; they don’t shed any light
on the absence of cognitive reappraisal of the delusional
idea that loved ones have been replaced by doubles. The
visual recognition of a familiar face results from both
the conscious recognition of the face and the limbic-
mediated emotional arousal that accompanies the con-
scious recognition, which is responsible for the sense of
familiarity [29]. Patients with Capgras delusion do not
only lack familiarity with their loved ones, they also ex-
plain this unusual sensation with a delusion. Ramachan-
dran argues that Capgras may arise from the conjunction
of two lesions: one affecting the brain’s ability to attach
emotional significance to a familiar face, and one affect-
ing the global consistency-checking mechanism in the
right hemisphere [28]. A recent imaging study has pro-
posed that Capgras may result from dysfunctional neural
activity in parts of the left extended face processing sys-
tem, which are also activated in Theory of Mind tasks,
and abnormalities in the right middle frontal gyrus [30].
Psychiatric symptoms in PD are very often related to
cognitive decline [31,32], but the exact patho-physiological
mechanisms underpinning of Capgras in PD remain un-
clear. It has been proposed that delusional misidentifica-
tion in PD may result from combination of dopaminergicpsychosis and cognitive decline [33,34], excessive dopa-
mine associated with L-dopa administration, diminished
acetylcholine, or both [17]. Here we describe a variant of
Capgras involving our patient’s domestic pets and inani-
mate objects, but sparing her husband and son. The
neurobiological underpinnings of variants of Capgras de-
lusion not involving the visual processing of human faces
remain unclear, but may result from decoupling of visual
recognition of objects and attribution of significance.
Similarly to “regular” Capgras, the patients are not im-
paired in overt object recognition, but fail to identify the
object as their own (i.e. lack of familiarity). Moreover,
there is a cognitive bias which results in the delusional ex-
planation of said lack of familiarity (“it doesn’t look famil-
iar, therefore it must be a double”).
Given the clinical history, onset and evolution of symp-
toms we believe our patient’s delusion resulted from the
overlap of dopaminergic medication and MCI in executive
functions.
Clinicians should be aware of the possibility of mis-
identification syndromes, including Capgras delusion, in
patients with PD, particularly in those with MCI receiv-
ing dopaminergic medication.
Consent
The patient was provided with a thorough explanation
of all procedures before she signed informed consent.
Informed consent was obtained for publication of this
case report. A copy of the written consent is available
for review by the Editor of this journal.
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